Digitisation | April 01, 2022
Arzeda closes US$33 million Series B funding
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
The plant is scheduled to come on stream in September 2024
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
It paves the way for an industry Code of Good Practice
The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA
Subscribe To Our Newsletter & Stay Updated
